Product details

In 2005, Kevin Sharer reflects on the challenges of sustaining the growth and success that have brought Amgen to the position of third-largest US pharmaceuticals company by market capitalization and the challenge of maintaining the higher P/E ratio it traditionally held. Profiles the leadership and development of Sharer, tracing his career from the US Navy through McKinsey and Co, GE, and MCI to his entrance at Amgen as President and Chief Operations Officer. Provides information on the history and business of Amgen and its science-based discovery model. Provides information about the protagonist's career, management style, learning style, aspirations, and motivations. Raises questions about leadership in sustaining discovery-driven growth and leadership succession.